|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 68.90 EUR | +0.58% |
|
+2.53% | +8.25% |
| 06-23 | Orion's Investigational Drug Wins EU Orphan Drug Designation to Treat Malignant Mesothelioma | MT |
| 06-16 | Digia Unit to Provide Data Integration, AI Analytics for Finnish Health Sector Project | MT |
| Market Cap | 9.71B 11.05B 8.94B 8.37B 15.69B 1,047B 15.95B 107B 41.57B 513B 41.47B 40.58B 1,785B | P/E 2026 * |
17.6x | P/E 2027 * | 14.9x |
|---|---|---|---|---|---|
| Enterprise Value | 9.61B 10.93B 8.85B 8.29B 15.52B 1,036B 15.78B 106B 41.14B 508B 41.04B 40.16B 1,766B | EV / Sales 2026 * |
4.62x | EV / Sales 2027 * | 3.99x |
| Free-Float |
90.5% | Yield 2026 * |
2.77% | Yield 2027 * | 3.07% |
Last Transcript: Orion Oyj
| 1 day | +0.58% | ||
| 1 week | +2.53% | ||
| Current month | -3.77% | ||
| 1 month | -3.30% | ||
| 3 months | +2.53% | ||
| 6 months | +8.42% | ||
| Current year | +8.25% |
| 1 week | 66.1 |  | 69.6 |
| 1 month | 66.1 | | 72.5 |
| Current year | 62.7 | | 75.3 |
| 1 year | 56.5 | | 75.3 |
| 3 years | 31.86 | | 75.3 |
| 5 years | 31.86 | | 75.3 |
| 10 years | 22.57 | | 75.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 01/11/2022 | |
René Lindell
DFI | Director of Finance/CFO | 50 | 01/05/2024 |
| Chief Operating Officer | 46 | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 22/03/2017 | |
Hilpi Rautelin
BRD | Director/Board Member | 65 | 22/03/2017 |
Kari Jussi Aho
BRD | Director/Board Member | 66 | 06/05/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 08/08/25 | Sell | Chief Operating Officer | 4,000 | 0.0122% | ||
| 04/08/25 | Sell | Executive/Senior Manager | 724 | 0.0022% | ||
| 04/08/25 | Sell | Executive/Senior Manager | 1,600 | 0.0049% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.58% | +2.53% | +7.82% | +80.27% | 11.04B | |
| +0.45% | -1.37% | +43.66% | +141.28% | 983B | |
| +3.37% | +1.66% | +58.00% | +44.48% | 557B | |
| +2.07% | +5.52% | +27.75% | +72.72% | 406B | |
| +0.25% | -1.30% | +22.76% | +15.66% | 314B | |
| +2.26% | +2.30% | +30.42% | +18.98% | 273B | |
| +2.61% | +3.11% | +29.81% | +36.09% | 272B | |
| +2.60% | +9.79% | -31.71% | -43.45% | 203B | |
| +0.66% | -0.24% | +27.37% | +52.79% | 186B | |
| +0.14% | -1.71% | +17.76% | +61.42% | 155B | |
| Average | +1.48% | +0.86% | +23.36% | +48.02% | 336.14B | |
| Weighted average by Cap. | +1.54% | +0.19% | +33.18% | +66.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.08B 2.37B 1.92B 1.79B 3.36B 224B 3.42B 23.02B 8.91B 110B 8.89B 8.7B 383B | 2.35B 2.68B 2.17B 2.03B 3.8B 254B 3.86B 26.02B 10.07B 124B 10.05B 9.83B 432B |
| Net income | 550M 626M 506M 474M 888M 59.25B 903M 6.08B 2.35B 29.07B 2.35B 2.3B 101B | 649M 739M 598M 560M 1.05B 70B 1.07B 7.18B 2.78B 34.35B 2.77B 2.71B 119B |
| Net Debt | -101M -115M -92.74M -86.82M -163M -10.85B -165M -1.11B -431M -5.33B -430M -421M -18.51B | -313M -356M -288M -270M -505M -33.72B -514M -3.46B -1.34B -16.55B -1.34B -1.31B -57.51B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/06/26 | €68.90 | +0.58% | 200,531 |
| 22/06/26 | €68.50 | +1.71% | 372,530 |
| 18/06/26 | €67.35 | -1.25% | 1,014,791 |
| 17/06/26 | €68.20 | +1.49% | 256,281 |
| 16/06/26 | €67.20 | +0.90% | 211,991 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ORNBV Stock
Select your edition
All financial news and data tailored to specific country editions
